Biozen secures FDA 510(k) clearance for BP1000 device
Biozen plans to introduce BP1000 to the US market in phases, with broader commercial availability targeted for late 2026.
12 May 2026
12 May 2026
Biozen plans to introduce BP1000 to the US market in phases, with broader commercial availability targeted for late 2026.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.